Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
about
Systemic pharmacological treatments for chronic plaque psoriasisPromising new treatments for psoriasisLeukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory diseaseAcupuncture for psoriasis: protocol for a systematic reviewSubcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis.Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece.Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment.Histological Stratification of Thick and Thin Plaque Psoriasis Explores Molecular Phenotypes with Clinical Implications.Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsCalcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasisAn evolution in switching therapy for psoriasis patients who fail to meet treatment goals.The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyLong term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritisCost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.Sequential use of biologics in moderate-to-severe plaque psoriasis: case studies illustrating an individualized approach.Biological treatments for moderate-to-severe psoriasis: indirect comparison.Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points.Systemic therapies for psoriasis: an evidence-based update.Treatment of psoriasis: focus on clinic-based management with infliximab.Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.Cellular sources of IL-17 in psoriasis: a paradigm shift?Factors affecting response to biologic treatment in psoriasis.Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: a comprehensive meta-analysis of randomized controlled trials.Adalimumab: A Review in Chronic Plaque Psoriasis.Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch.PGRN Suppresses Inflammation and Promotes Autophagy in Keratinocytes Through the Wnt/β-Catenin Signaling Pathway.Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region.Short-term efficacy and safety of new biological agents targeting the interleukin-23-T helper 17 pathway for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis.Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review.Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.
P2860
Q24188334-976B1DC5-FD4F-405E-BC29-E82D844F9566Q24598008-8538CA89-C5B7-4F07-8DF4-FBC199D4A602Q26822941-D9CABDC3-4565-4087-B411-1919454BE4DAQ28082927-6AB1D961-A2F8-49E3-A4DA-2FF407A49A3BQ31137103-8BDB4001-AF5A-470F-B8FC-258CF4C219BCQ34351604-EE5E1B07-2436-4F01-8D13-D7B440DED884Q34944668-92C5CDFB-7711-4C64-B636-58093CAC052DQ35658540-8477832C-208C-454C-A444-08BE7DA6C877Q35692116-A0DBA65A-C3DF-4442-8C7E-2CCCAFCA50E1Q35860158-AE108325-B16F-4C51-9B8D-E44E380D0BBEQ36190962-3B52FA51-0A14-442E-B30B-89180B79C753Q36247035-4E63FB4F-908B-425B-A52A-1D9104B2EA48Q36628064-0110E663-3142-4FD0-BD76-126F4DECD85FQ36694323-809CD04E-5373-4C7D-A45A-421530D88E93Q37295966-E3440EB4-5656-41BA-809B-6FCAD6B40A0AQ37301134-FD1648F1-435B-4B66-A2FF-8D9E7D06438EQ37494175-205B0625-AAE1-4F60-8AFC-DAE180027CD9Q37724124-92098562-A768-4927-B80F-A57BF4DAF525Q38013239-30A8468A-3774-4E13-93F9-FF557A54C475Q38053456-8964117C-F373-4302-99B9-0373E0184022Q38084746-3F86FDB6-113C-4957-A105-7B25AF642D8CQ38127746-DAC51A6D-05BF-489D-B6D6-F01E83FEF813Q38137277-EBF86733-14B9-4489-B9CF-4BBDDE947553Q38185297-87CDB526-AA94-413A-9567-7576A3D4C94FQ38207916-E4A663C1-443E-4D00-BB59-193D7A147E13Q38231348-765A88A0-2666-4F77-A75A-FEEB8B61DEF3Q38231403-C98C1420-6454-4549-AC8F-6E5F002488E4Q38232919-B72166F0-FADB-42B1-BBEF-7603DACD3373Q38257403-B6E4D9AD-0149-4966-8063-25CC0BC49DD6Q38268725-BBF8F757-7802-4ED9-AAF7-22206149503CQ38639495-2701ADBF-55A6-4A88-B337-4F64F1E599F3Q38764424-58B58519-82B0-4C5E-AEAF-9CEBAF0D31FDQ38767538-0C806938-1EC4-4ED7-8850-42D9E1F861CDQ38812025-ACE2C0D4-B20C-4848-86C7-A222D6480F0BQ38838470-CE6F458A-B97B-4712-B9B1-78A77CC6446BQ38862695-6729ECF8-B97E-4718-BB88-52504E11597FQ38939797-EEEF6F2F-BFD9-4C88-BB6E-3917E09F26D2Q38983429-7529AF8B-C07A-4DCB-AA4D-4F916D773ADBQ39004668-E488A918-645F-4D86-8525-ADECBE00F648Q39070719-192EF70F-3303-417A-BBB6-DB4C98FAD5AA
P2860
Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Efficacy of biologics in the t ...... randomized controlled trials.
@en
Efficacy of biologics in the t ...... randomized controlled trials.
@nl
type
label
Efficacy of biologics in the t ...... randomized controlled trials.
@en
Efficacy of biologics in the t ...... randomized controlled trials.
@nl
prefLabel
Efficacy of biologics in the t ...... randomized controlled trials.
@en
Efficacy of biologics in the t ...... randomized controlled trials.
@nl
P2093
P1476
Efficacy of biologics in the t ...... randomized controlled trials.
@en
P2093
P304
P356
10.1111/J.1365-2133.2011.10583.X
P407
P577
2011-11-11T00:00:00Z